Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Barr Will Launch Generic Ovcon 35 In October After Regaining Rights To ANDA

This article was originally published in The Pink Sheet Daily

Executive Summary

Under pressure from FTC, Warner Chilcott ends an exclusive agreement which was blocking Barr entry until May 2009.

You may also be interested in...



FTC Enjoins Warner Chilcott From Providing “Anything Of Value” To ANDA Filers

Commission settles charges against the brand drug maker related to generic Ovcon 35.

FTC Enjoins Warner Chilcott From Providing “Anything Of Value” To ANDA Filers

Commission settles charges against the brand drug maker related to generic Ovcon 35.

Cephalon Provigil Generics Settlements Under FTC Investigation

FTC seeking information on four deals that postpone generic entry.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS064920

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel